These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28689438)

  • 1. The cost and value of glioblastoma therapy.
    Cagney DN; Alexander BM
    Expert Rev Anticancer Ther; 2017 Aug; 17(8):657-659. PubMed ID: 28689438
    [No Abstract]   [Full Text] [Related]  

  • 2. Should the cost of care for patients with glioblastoma influence treatment decisions?
    Dropcho EJ
    Continuum (Minneap Minn); 2012 Apr; 18(2):416-20. PubMed ID: 22810136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is it reasonable to deny older patients treatment for glioblastoma?
    Gusmano MK
    J Law Med Ethics; 2014; 42(2):183-9. PubMed ID: 25040382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment costs for glioblastoma multiforme in Nova Scotia.
    Mendez I; Jacobs P; MacDougall A; Schultz M
    Can J Neurol Sci; 2001 Feb; 28(1):61-5. PubMed ID: 11252298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of patient age on glioblastoma perioperative treatment costs: a value driven outcome database analysis.
    Sherrod BA; Gamboa NT; Wilkerson C; Wilde H; Azab MA; Karsy M; Jensen RL; Menacho ST
    J Neurooncol; 2019 Jul; 143(3):465-473. PubMed ID: 31055681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current trends in the management of glioblastoma in a French University Hospital and associated direct costs.
    Henaine AM; Paubel N; Ducray F; Diebold G; Frappaz D; Guyotat J; Cartalat-Carel S; Aulagner G; Hartmann D; Honnorat J; Armoiry X
    J Clin Pharm Ther; 2016 Feb; 41(1):47-53. PubMed ID: 26748577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. I could lose everything: understanding the cost of a brain tumor.
    Bradley S; Sherwood PR; Donovan HS; Hamilton R; Rosenzweig M; Hricik A; Newberry A; Bender C
    J Neurooncol; 2007 Dec; 85(3):329-38. PubMed ID: 17581698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioblastoma: background, standard treatment paradigms, and supportive care considerations.
    Ellor SV; Pagano-Young TA; Avgeropoulos NG
    J Law Med Ethics; 2014; 42(2):171-82. PubMed ID: 25040381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme: a report from the EORTC 26981/22981 NCI-C CE3 Intergroup Study.
    Lamers LM; Stupp R; van den Bent MJ; Al MJ; Gorlia T; Wasserfallen JB; Mittmann N; Jin Seung S; Crott R; Uyl-de Groot CA;
    Cancer; 2008 Mar; 112(6):1337-44. PubMed ID: 18213621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost of brain tumour in Europe.
    Ekman M; Westphal M
    Eur J Neurol; 2005 Jun; 12 Suppl 1():45-9. PubMed ID: 15877778
    [No Abstract]   [Full Text] [Related]  

  • 11. Toward Value in Health Care: Perspectives, Priorities, and Policy.
    Wheeler SB; Spencer J; Rotter J
    N C Med J; 2018; 79(1):62-65. PubMed ID: 29439109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can we afford to add chemotherapy to radiotherapy for glioblastoma multiforme? Cost-identification analysis of concomitant and adjuvant treatment with temozolomide until patient death.
    Wasserfallen JB; Ostermann S; Pica A; Mirimanoff RO; Leyvraz S; Villemure JG; Stupp R
    Cancer; 2004 Nov; 101(9):2098-105. PubMed ID: 15389472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From Cardiologist to Patient….
    Alguire C
    Circ Cardiovasc Qual Outcomes; 2018 Jul; 11(7):e004991. PubMed ID: 30002141
    [No Abstract]   [Full Text] [Related]  

  • 14. Economic Evaluation of Bevacizumab for the First-Line Treatment of Newly Diagnosed Glioblastoma Multiforme.
    Kovic B; Xie F
    J Clin Oncol; 2015 Jul; 33(20):2296-302. PubMed ID: 26014296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of glioblastoma: comparison of clinical practices and cost-effectiveness in two cohorts of patients (2008 versus 2004) diagnosed in a French university hospital.
    Diebold G; Ducray F; Henaine AM; Frappaz D; Guyotat J; Cartalat-Carel S; Breant V; Fouquet A; Aulagner G; Honnorat J; Armoiry X
    J Clin Pharm Ther; 2014 Dec; 39(6):642-8. PubMed ID: 25164371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization and cost of health care services associated with primary malignant brain tumors in the United States.
    Kutikova L; Bowman L; Chang S; Long SR; Thornton DE; Crown WH
    J Neurooncol; 2007 Jan; 81(1):61-5. PubMed ID: 16773215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant therapy in the treatment of malignant glioma.
    Kim RY; Langford KH; Roth RE
    J Med Assoc State Ala; 1977 Oct; 47(4):39-41. PubMed ID: 200689
    [No Abstract]   [Full Text] [Related]  

  • 18. Modern management of high grade glioma, part II.
    Yang I; Han SJ
    Neurosurg Clin N Am; 2012 Jul; 23(3):xiii-xiv. PubMed ID: 22748664
    [No Abstract]   [Full Text] [Related]  

  • 19. Present trend in the primary treatment of aggressive malignant glioma: glioblastoma multiforme.
    Parvez T
    Technol Cancer Res Treat; 2008 Jun; 7(3):241-8. PubMed ID: 18473496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive microwave hyperthermia for treatment of glioma.
    Wen HL; Dahele JS
    Chin Med J (Engl); 1984 Nov; 97(11):813-8. PubMed ID: 6100442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.